Cargando…
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
Background. For young South African women at risk for human immunodeficiency virus (HIV) infection, preexposure prophylaxis (PrEP) is one of the few effective prevention options available. Long-acting injectable PrEP, which is in development, may be associated with greater adherence, compared with t...
Autores principales: | Walensky, Rochelle P., Jacobsen, Margo M., Bekker, Linda-Gail, Parker, Robert A., Wood, Robin, Resch, Stephen C., Horstman, N. Kaye, Freedberg, Kenneth A., Paltiel, A. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837902/ https://www.ncbi.nlm.nih.gov/pubmed/26681778 http://dx.doi.org/10.1093/infdis/jiv523 |
Ejemplares similares
-
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017) -
Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020) -
Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis
por: Luong Nguyen, Liem B, et al.
Publicado: (2020) -
The Survival Benefits of Antiretroviral Therapy in South
Africa
por: April, Michael D., et al.
Publicado: (2014) -
Increased HIV Transmissions With Reduced Insurance Coverage for HIV Preexposure Prophylaxis: Potential Consequences of Braidwood Management v. Becerra
por: Paltiel, A David, et al.
Publicado: (2023)